130 related articles for article (PubMed ID: 18729096)
21. Bis(alpha-furancarboxylato)oxovanadium(IV) prevents and improves dexamethasone-induced insulin resistance in 3T3-L1 adipocytes.
Zuo YQ; Liu WP; Niu YF; Tian CF; Xie MJ; Chen XZ; Li L
J Pharm Pharmacol; 2008 Oct; 60(10):1335-40. PubMed ID: 18812026
[TBL] [Abstract][Full Text] [Related]
22. A new halogenated antidiabetic vanadyl complex, bis(5-iodopicolinato)oxovanadium(IV): in vitro and in vivo insulinomimetic evaluations and metallokinetic analysis.
Takino T; Yasui H; Yoshitake A; Hamajima Y; Matsushita R; Takada J; Sakurai H
J Biol Inorg Chem; 2001 Feb; 6(2):133-42. PubMed ID: 11293406
[TBL] [Abstract][Full Text] [Related]
23. Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential.
Thompson KH; Liboiron BD; Sun Y; Bellman KD; Setyawati IA; Patrick BO; Karunaratne V; Rawji G; Wheeler J; Sutton K; Bhanot S; Cassidy C; McNeill JH; Yuen VG; Orvig C
J Biol Inorg Chem; 2003 Jan; 8(1-2):66-74. PubMed ID: 12459900
[TBL] [Abstract][Full Text] [Related]
24. Enhancement of insulin signaling pathway in adipocytes by oxovanadium(IV) complexes.
Basuki W; Hiromura M; Adachi Y; Tayama K; Hattori M; Sakurai H
Biochem Biophys Res Commun; 2006 Oct; 349(3):1163-70. PubMed ID: 16970914
[TBL] [Abstract][Full Text] [Related]
25. Bis(6-ethylpicolinato)oxovanadium(IV) complex with normoglycemic activity in KK-A(y) mice.
Sasagawa T; Yoshikawa Y; Kawabe K; Sakurai H; Kojima Y
J Inorg Biochem; 2002 Jan; 88(1):108-12. PubMed ID: 11750032
[TBL] [Abstract][Full Text] [Related]
26. Amelioration of insulin resistance in diabetic ob/ob mice by a new type of orally active insulin-mimetic vanadyl complex: bis(1-oxy-2-pyridinethiolato)oxovanadium(IV) with VO(S(2)O(2)) coordination mode.
Takeshita S; Kawamura I; Yasuno T; Kimura C; Yamamoto T; Seki J; Tamura A; Sakurai H; Goto T
J Inorg Biochem; 2001 Jun; 85(2-3):179-86. PubMed ID: 11410238
[TBL] [Abstract][Full Text] [Related]
27. A new concept: the use of vanadium complexes in the treatment of diabetes mellitus.
Sakurai H
Chem Rec; 2002; 2(4):237-48. PubMed ID: 12203906
[TBL] [Abstract][Full Text] [Related]
28. The pharmacology of the insulinomimetic effect of zinc complexes.
Sakurai H; Adachi Y
Biometals; 2005 Aug; 18(4):319-23. PubMed ID: 16158223
[TBL] [Abstract][Full Text] [Related]
29. Screening and identification of disaccharides with insulin mimetic activity against L6 cells.
Yamasaki K; Hishiki R; Kato E; Kawabata J
Biosci Biotechnol Biochem; 2012; 76(4):841-2. PubMed ID: 22484948
[TBL] [Abstract][Full Text] [Related]
30. Novel vanadyl complexes of alginate saccharides: synthesis, characterization, and biological activities.
Liu S; Liu G; Yi Y
Carbohydr Polym; 2015 May; 121():86-91. PubMed ID: 25659675
[TBL] [Abstract][Full Text] [Related]
31. Mechanism on insulin-like action of vanadyl sulfate: studies on interaction between rat adipocytes and vanadium compounds.
Nakai M; Watanabe H; Fujiwara C; Kakegawa H; Satoh T; Takada J; Matsushita R; Sakurai H
Biol Pharm Bull; 1995 May; 18(5):719-25. PubMed ID: 7492989
[TBL] [Abstract][Full Text] [Related]
32. Effects of some vanadyl coordination compounds on the in vitro insulin release from rat pancreatic islets.
Conconi MT; DeCarlo E; Vigolo S; Grandi C; Bandoli G; Sicolo N; Tamagno G; Parnigotto PP; Nussdorfer GG
Horm Metab Res; 2003 Jul; 35(7):402-6. PubMed ID: 12931270
[TBL] [Abstract][Full Text] [Related]
33. Bis(maltolato)vanadium(III)-polypyridyl complexes: synthesis, characterization, DNA cleavage, and insulin mimetic activity.
Islam MN; Kumbhar AA; Kumbhar AS; Zeller M; Butcher RJ; Dusane MB; Joshi BN
Inorg Chem; 2010 Sep; 49(18):8237-46. PubMed ID: 20715814
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of insulin-mimetic activities of vanadyl and zinc(II) complexes from the viewpoint of heterocyclic bidentate ligands.
Katoh A; Matsumura Y; Yoshikawa Y; Yasui H; Sakurai H
J Inorg Biochem; 2009 Apr; 103(4):567-74. PubMed ID: 19162327
[TBL] [Abstract][Full Text] [Related]
35. Comparison of anti-hyperglycemic effect amongst vanadium, molybdenum and other metal maltol complexes.
Thompson KH; Chiles J; Yuen VG; Tse J; McNeill JH; Orvig C
J Inorg Biochem; 2004 May; 98(5):683-90. PubMed ID: 15134913
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, Characterization, and Anti-diabetic Activity of Some Novel Vanadium-Folate-Amino Acid Materials.
Naglah AM; Al-Omar MA; Almehizia AA; Obaidullah AJ; Bhat MA; Kalmouch A; Al-Wasidi AS; Al-Humaidi JY; Refat MS
Biomolecules; 2020 May; 10(5):. PubMed ID: 32443614
[TBL] [Abstract][Full Text] [Related]
37. Possible mode of action for insulinomimetic activity of vanadyl(IV) compounds in adipocytes.
Kawabe K; Yoshikawa Y; Adachi Y; Sakurai H
Life Sci; 2006 May; 78(24):2860-6. PubMed ID: 16337244
[TBL] [Abstract][Full Text] [Related]
38. Glucose-lowering properties of vanadium compounds: comparison of coordination complexes with maltol or kojic acid as ligands.
Yuen VG; Caravan P; Gelmini L; Glover N; McNeill JH; Setyawati IA; Zhou Y; Orvig C
J Inorg Biochem; 1997 Nov; 68(2):109-16. PubMed ID: 9336969
[TBL] [Abstract][Full Text] [Related]
39. In vitro study of the insulin-like action of vanadyl-pyrone and -pyridinone complexes with a VO(O4) coordination mode.
Rangel M; Tamura A; Fukushima C; Sakurai H
J Biol Inorg Chem; 2001 Feb; 6(2):128-32. PubMed ID: 11293405
[TBL] [Abstract][Full Text] [Related]
40. Insulinomimetic Zn complex (Zn(opt)2) enhances insulin signaling pathway in 3T3-L1 adipocytes.
Basuki W; Hiromura M; Sakurai H
J Inorg Biochem; 2007 Apr; 101(4):692-9. PubMed ID: 17316811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
